Your browser doesn't support javascript.
loading
Predictors of immune persistence induced by two-dose BBIBP-CorV vaccine in high-risk occupational population.
Yao, Tian; Guo, Yana; Xu, Xiuyang; Zhang, Xiaohong; Mu, Shengcai; Huo, Junfeng; Wei, Zhiyun; Liu, Ling; Li, Xiaoqing; Li, Hong; Xing, Rongqin; Feng, Yongliang; Chen, Jing; Feng, Lizhong; Wang, Suping.
Afiliação
  • Yao T; First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China.
  • Guo Y; School of Public Health, Shanxi Medical University, Taiyuan, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China.
  • Xu X; School of Public Health, Shanxi Medical University, Taiyuan, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China.
  • Zhang X; Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China; Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan, China.
  • Mu S; Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China; Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan, China.
  • Huo J; Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China; Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan, China.
  • Wei Z; Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China; Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan, China.
  • Liu L; Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China; Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan, China.
  • Li X; Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China; Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan, China.
  • Li H; Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China; Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan, China.
  • Xing R; Outpatient Department of Shanxi Aviation Industry Group Co. LTD, Taiyuan, China.
  • Feng Y; School of Public Health, Shanxi Medical University, Taiyuan, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China.
  • Chen J; Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China; Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan, China.
  • Feng L; Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China; Shanxi Provincial Key Laboratory for Major Infectious Disease Response, Taiyuan, China. Electronic address: 1508717672@qq.com.
  • Wang S; School of Public Health, Shanxi Medical University, Taiyuan, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China. Electronic address: supingwang@sxmu.edu.cn.
Vaccine ; 41(40): 5910-5917, 2023 09 15.
Article em En | MEDLINE | ID: mdl-37604725
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China